Dudnik et al. (20) reported that the expression of PD-L1 was slightly higher in BRAF-mutant NSCLC than unselected population of previously reported, and a higher TMB in BRAF mutated patients was also observed. Here, BRAF is linked to non-small cell lung carcinoma.